 | | | | The White House on Thursday said Americans have increased requests for at-home COVID-19 tests as the federal government prepares to stop providing free tests on Friday. | | | | | | A subsidiary of Dutch medical device maker Philips has agreed to pay over $24 million to resolve alleged false claims over respiratory-related medical equipment, the U.S. Justice Department said on Thursday. | | | | | | Gay rights activists from across Latin America have called for the region's governments to take firm steps to prevent the spread of monkeypox, saying a lack of will to provide vaccines and diagnose cases is hurting the region's gay and bisexual men. | | | | | | Illumina Inc , a U.S. maker of genetic analysis equipment, said on Thursday an administrative judge has ruled that its acquisition of cancer detection test maker Grail Inc will not hurt competition, allowing the deal to move forward. | | | | | | U.S. States seeking to enforce abortion bans will not be able to obtain medical or communications records of patients, doctors or others involved in helping women obtain care in California under a package of bills sent to Governor Gavin Newsom late on Wednesday. | | | | | | The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter. | | | | | | Canada on Thursday authorized Moderna Inc's bivalent COVID-19 shots for adults, adding the first Omicron-adapted vaccine to its arsenal just as falling temperatures are poised to force people indoors where the risk of infection is higher. | | | | | | Germany can next week start using COVID-19 vaccines which have been adapted for the Omicron variant and got approval for use in the European Union on Thursday, Health Minister Karl Lauterbach said. | | | | | | Johnson & Johnson has agreed to pay $40.5 million to settle New Hampshire's claims over the company's role in the U.S. opioid epidemic, averting a trial that had been scheduled to begin next week. | | | | | | The European Union's drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the Omicron variant, ahead of an anticipated rise in infections this winter. | | | | | |
